renal cancer

Home Tag

Banner web VHIO (1300 × 600 px) (3)

Immunotherapy-based combination of pembrolizumab plus lenvatinib as first-line treatment for patients with advanced non-clear cell renal cell carcinoma

Published in The Lancet Oncology (1) and co-authored by VHIO’s Cristina Suarez, results from the single-arm phase II KEYNOTE-B61 clinical…

Ok_elegida_por_ella

CheckMate 9ER: extended follow-up data further supports nivolumab plus cabozantinib as first-line treatment of advanced renal cell carcinoma

The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…